EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer

被引：249
|
作者：
Horn, Leora [1 ]
Pao, William [1 ]
机构：
[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 26期
关键词：
GROWTH-FACTOR RECEPTOR; ACTIVATING MUTATIONS; FUSION GENE; ALK KINASE; KRAS MUTATIONS; NEVER SMOKERS; PHASE-III; NPM-ALK; GEFITINIB; IDENTIFICATION;
D O I：
10.1200/JCO.2009.23.6661
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4232 / 4235
页数：4
相关论文
共 50 条
  • [31] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
    Aguado, Cristina
    Teixido, Cristina
    Gimenez-Capitan, Ana
    Gil, Maria de los Llanos
    Rodriguez, Sonia
    Viteri, Santiago
    Karachaliou, Niki
    Aldeguer, Erika
    Peg, Vicente
    Alonso, Lidia
    Molina-Vila, Miguel Angel
    Rosell, Rafael
    CANCER RESEARCH, 2017, 77
  • [32] The clinical impact of an EML4-ALK variant on survival following crizotinib treatment in patients with advanced ALK-rearranged non-small-cell lung cancer
    Seo, S.
    Woo, C. G.
    Lee, D. H.
    Choi, J.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1667 - 1668
  • [33] Continual Improvement of the Reliability of EML4-ALK Rearrangement Detection in Non-Small-Cell Lung Cancer A Long-Term Comparison of ALK Detection in China
    Peng, Rongxue
    Zhang, Rui
    Zhang, Jiawei
    Tan, Ping
    Han, Yanxi
    Zhang, Kuo
    Lin, Guigao
    Xie, Jiehong
    Li, Jinming
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (07): : 876 - 884
  • [34] EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
    Erik Thunnissen
    Lukas Bubendorf
    Manfred Dietel
    Göran Elmberger
    Keith Kerr
    Fernando Lopez-Rios
    Holger Moch
    Wlodzimierz Olszewski
    Patrick Pauwels
    Frédérique Penault-Llorca
    Giulio Rossi
    Virchows Archiv, 2012, 461 : 245 - 257
  • [35] A Multicenter Study of EGFR and EML4-ALK Detection in Non-Squamous, Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusion
    Shi, Xun
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S495 - S495
  • [36] EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
    Thunnissen, Erik
    Bubendorf, Lukas
    Dietel, Manfred
    Elmberger, Goran
    Kerr, Keith
    Lopez-Rios, Fernando
    Moch, Holger
    Olszewski, Wlodzimierz
    Pauwels, Patrick
    Penault-Llorca, Frederique
    Rossi, Giulio
    VIRCHOWS ARCHIV, 2012, 461 (03) : 245 - 257
  • [37] Crizotinib for recurring non-small-cell lung cancer with EML4-ALK fusion genes previously treated with alectinib: A phase II trial
    Harada, Daijiro
    Isozaki, Hideko
    Kozuki, Toshiyuki
    Yokoyama, Toshihide
    Yoshioka, Hiroshige
    Bessho, Akihiro
    Hosokawa, Shinobu
    Takata, Ichiro
    Takigawa, Nagio
    Hotta, Katsuyuki
    Kiura, Katsuyuki
    THORACIC CANCER, 2021, 12 (05) : 643 - 649
  • [38] The Biology and Clinical Features of Non–small Cell Lung Cancers with EML4-ALK Translocation
    Rathi N. Pillai
    Suresh S. Ramalingam
    Current Oncology Reports, 2012, 14 : 105 - 110
  • [39] Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion
    Aguado, Cristina
    Gil, Maria-de-los-Llanos
    Yeste, Zaira
    Gimenez-Capitan, Ana
    Teixido, Cristina
    Karachaliou, Niki
    Viteri, Santiago
    Rosell, Rafael
    Molina-Vila, Miguel A.
    ONCOTARGETS AND THERAPY, 2018, 11 : 1117 - 1120
  • [40] Clinical Outcomes and ALK Resistance Mutations in ALK plus Non-Small Cell Lung Cancer According to EML4-ALK Variant
    Lin, J.
    Zhu, V.
    Yoda, S.
    Yeap, B.
    Jessop, N.
    Schrock, A.
    Dagogo-Jack, I.
    Gowen, K.
    Stephens, P. J.
    Ross, J.
    Ali, S.
    Miller, V.
    Gainor, J.
    Hata, A.
    Iafrate, A.
    Ou, S.
    Shaw, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1828 - S1828
12345